…
IP Group Plc is a private equity and venture capital firm specializing in seed/startup, early venture, emerging growth, mature, mid venture, late venture, incubation, mezzanine in growth capital companies. It prefers to invest in energy, materials, healthcare, information technology, communication services, utilities, life sciences, deeptech, cleantech, chemicals, science and innovation companies. The firm prefers to invest in Europe, typically invests in companies based in or willing to relocate to North East England. It firm prefers to invest between £0.050 million ($0.08 million) and £1.25 million ($2.01 million) with revenue up to £45 million ($71 million). IP Group Plc was founded in 2001 and is based in London, United Kingdom with additional offices in Hong Kong, Hong Kong and Melbourne, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 64.80M | -206.70M | -176.30M | -343.50M | 454.60M |
| Minority interest | - | 4.40M | 3.50M | 2.50M | 0.00M |
| Net income | 66.80M | -205.60M | -171.30M | -344.50M | 449.30M |
| Selling general administrative | - | 7.30M | 11.00M | 9.70M | 9.10M |
| Gross profit | 44.40M | -179.50M | -154.60M | -313.20M | 490.40M |
| Reconciled depreciation | - | 0.60M | 0.60M | 0.60M | 1.60M |
| Ebit | 71.20M | -204.00M | -180.50M | -327.10M | 454.60M |
| Ebitda | 71.70M | - | -179.90M | -326.50M | 456.20M |
| Depreciation and amortization | 0.50M | 0.60M | 0.60M | 0.60M | 1.60M |
| Operating income | -56.80M | -204.00M | -180.50M | -327.10M | 454.60M |
| Other operating expenses | 101.70M | 24.50M | 25.90M | 30.30M | 35.80M |
| Interest expense | 6.40M | 6.70M | 5.60M | 13.40M | 19.00M |
| Tax provision | - | 0.30M | -1.90M | 1.00M | 5.30M |
| Interest income | - | 16.70M | 14.50M | 2.20M | 0.40M |
| Net interest income | - | 10.00M | 8.90M | -11.20M | -18.60M |
| Income tax expense | -2.10M | 0.30M | -1.90M | 1.00M | 5.30M |
| Total revenue | 44.90M | -179.50M | -154.60M | -313.20M | 490.40M |
| Total operating expenses | 101.20M | 24.50M | 25.90M | 30.30M | 35.80M |
| Cost of revenue | 0.50M | - | - | - | - |
| Total other income expense net | 121.60M | -2.70M | 4.20M | -16.40M | -19.00M |
| Net income from continuing ops | - | -207.00M | -174.40M | -344.50M | 449.30M |
| Net income applicable to common shares | - | - | - | -341.50M | 448.20M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
| Total assets | 1098.60M | 1151.20M | 1411.60M | - | 1557.80M |
| Intangible assets | 0.40M | 0.00M | 0.00M | - | 0.00M |
| Other current assets | - | 19.40M | 2.20M | - | 0.70M |
| Total liab | 123.50M | 198.70M | 221.30M | - | 181.70M |
| Total stockholder equity | 975.10M | 966.00M | 1199.40M | - | 1381.70M |
| Other current liab | - | 11.20M | 15.20M | - | -1.30M |
| Common stock | 17.80M | 19.50M | 21.30M | - | 21.30M |
| Capital stock | - | 19.50M | 21.30M | - | 21.30M |
| Retained earnings | 851.30M | 842.20M | 1075.60M | - | 1257.90M |
| Other liab | - | - | - | - | 63.90M |
| Good will | - | 0.40M | 0.40M | - | 0.40M |
| Other assets | - | 1151.20M | 1411.60M | - | 194.90M |
| Cash | 16.50M | 115.60M | 100.90M | - | 88.70M |
| Total current liabilities | 119.70M | 18.80M | 23.40M | - | 1.30M |
| Current deferred revenue | - | - | -1.40M | - | - |
| Net debt | 103.20M | -115.60M | 55.50M | - | 13.10M |
| Short term debt | 119.70M | 7.30M | 7.70M | - | - |
| Short long term debt total | 119.70M | 150.00M | 156.40M | - | 101.80M |
| Other stockholder equity | 102.50M | 102.50M | 102.50M | - | 102.50M |
| Property plant equipment | - | - | - | - | 0.40M |
| Total current assets | 19.70M | 305.70M | 236.50M | - | 103.60M |
| Long term investments | - | 824.10M | 1165.50M | - | 1258.50M |
| Net tangible assets | - | - | - | - | 1381.30M |
| Short term investments | - | 170.00M | 126.00M | - | - |
| Net receivables | 3.20M | 0.70M | 7.40M | - | 14.90M |
| Inventory | - | - | 0.00M | - | - |
| Accounts payable | - | 0.30M | 0.50M | - | 1.30M |
| Accumulated other comprehensive income | 3.50M | 1.80M | 0.00M | - | - |
| Non currrent assets other | 0.10M | 20.20M | 7.80M | - | -1259.30M |
| Non current assets total | 1078.90M | 845.50M | 1175.10M | - | 1259.30M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 82.90M | -4.40M | -2.30M | 33.60M |
| Change to liabilities | - | - | - | -2.80M | 8.80M |
| Total cashflows from investing activities | -32.10M | 82.90M | -4.40M | -2.30M | 26.30M |
| Net borrowings | - | -6.50M | 53.30M | 29.10M | -16.10M |
| Total cash from financing activities | -52.50M | -42.90M | 34.70M | 8.80M | -58.30M |
| Change to operating activities | - | - | - | -0.20M | 24.30M |
| Net income | 66.80M | -206.70M | -171.30M | -343.50M | 456.00M |
| Change in cash | -99.10M | 14.70M | 12.20M | -17.00M | -21.90M |
| Begin period cash flow | 115.60M | 100.90M | 88.70M | 105.70M | 127.60M |
| End period cash flow | 16.50M | 115.60M | 100.90M | 88.70M | 105.70M |
| Total cash from operating activities | -14.50M | -25.10M | -17.90M | -23.50M | 10.00M |
| Depreciation | 0.50M | 0.60M | 0.60M | 0.60M | 1.60M |
| Other cashflows from investing activities | 10.10M | 7.10M | 5.00M | - | - |
| Dividends paid | - | 0.00M | 13.00M | 12.30M | 15.00M |
| Change to account receivables | -1.60M | -0.70M | 1.30M | -0.50M | -3.00M |
| Sale purchase of stock | -45.70M | -29.60M | -0.10M | -8.00M | -27.20M |
| Other cashflows from financing activities | -0.50M | -6.80M | -5.50M | 59.40M | 26.30M |
| Change to netincome | - | - | - | 320.90M | -469.90M |
| Capital expenditures | 14.50M | 0.00M | 0.00M | 0.30M | 0.20M |
| Change in working capital | -3.90M | -8.00M | 0.30M | -3.30M | 5.80M |
| Stock based compensation | - | - | -2.10M | - | - |
| Other non cash items | -77.90M | 189.00M | 154.60M | 322.70M | -453.40M |
| Free cash flow | - | -25.10M | -17.90M | -23.80M | 9.80M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| IPO IP Group |
1.60 2.25% |
72.70 | 7.73 | 9.53 | 5.99 | 0.51 | 6.76 | 42.15 |
| MNTN Schiehallion Fund Ltd |
-0.01 0.46% |
2.18 | 0.05 | - | 4.35 | 1.25 | 5.65 | - |
| BHMU BH Macro Limited |
- -% |
4.29 | 0.09 | - | 39.01 | 0.71 | 6.47 | - |
| TFG Tetragon Financial Group Ltd |
0.15 1.00% |
15.10 | 0.02 | 7.04 | 1.16 | 0.31 | 2.06 | 6.56 |
| BPCR BioPharma Credit PLC |
0.00 0.41% |
0.98 | 0.09 | - | 6.73 | 0.91 | 7.95 | - |
IP Group Plc is a private equity and venture capital firm specializing in seed/startup, early venture, emerging growth, mature, mid venture, late venture, incubation, mezzanine in growth capital companies. It prefers to invest in energy, materials, healthcare, information technology, communication services, utilities, life sciences, deeptech, cleantech, chemicals, science and innovation companies. The firm prefers to invest in Europe, typically invests in companies based in or willing to relocate to North East England. It firm prefers to invest between £0.050 million ($0.08 million) and £1.25 million ($2.01 million) with revenue up to £45 million ($71 million). IP Group Plc was founded in 2001 and is based in London, United Kingdom with additional offices in Hong Kong, Hong Kong and Melbourne, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Gregory Simon Smith A.C.A., ACA | CEO & Exec. Director | 1979 |
| Mr. David Graham Baynes | COO, CFO & Exec. Director | 1964 |
| Mr. Alan John Aubrey F.C.A., FCA | Consultant | 1962 |
| Mr. Michael Charles Nettleton Townend | Consultant | 1962 |
| Ms. Angela Leach | Gen. Counsel & Company Sec. | NA |
| Ms. Helen Redmond | Sr. Compliance & Risk Mang. | NA |
| Ms. Liz Vaughan-Adams | Director of Communications | NA |
| Mr. Anthony York | Group People Director | NA |
| Mr. Stuart Thompson | Talent Partner & Head of IP Exec | NA |
| Dr. Mark Alexander Reilly Ph.D. | Managing Partner of Technology & Board Observer | 1980 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.